|
The new edition of this market-leading cardiac drug resource equips you with the latest advances in cardiovascular pharmacology, one of the most rapidly changing areas of medicine. It not only offers in-depth information on all of the drug classes used to treat heart disease, but also covers new drug classes, drug use for single and multiple problem management, and more. Dynamic full-color drawings illustrate key pharmacological and physiological actions, and a user-friendly organization directs you to the information you need. An increased emphasis on the practical use of drugs saves you valuable time in researching relevant information.
|
|
|
|
|
About the Author
|
Lionel H. Opie, MD, DPhiL, DSc, FRCP, Codirector, Cape Heart Centre annd Medical Research Councill's Interuniversity Heart Research Group; Professor of Medicine, University of Cape Town Medical School, Cape Town, South Africa; Visiting Professor, 1984-1998, Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, CA.
Bernard J. Gersh, MB, ChB, DPhil, FACC, Professor of Medicine and Chair, Cardiovascular Education, Mayo Medical School; Consultant, Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN.
|
|
|
|
|
New to edition
|
|
? Incorporates all-new drugs, preparations, and clinical trial data in each chapter, equipping you to make the most up-to-date, informed clinical decisions.
? Offers expanded coverage of comorbid diseases through new chapters on metabolic syndrome, hyperglycemia, and diabetes.
? Features an increased emphasis on the practical use of drugs through highlighted sections and key illustrations, saving you time in searching for relevant information.
? Presents the work of several new contributors who represent a broad international perspective to equip you with a global view of cardiovascular pharmacology.
|
|
|
ß- Blocking Agents
Nitrates and Newer Antianginals
Calcium Channel Blockers
Diuretics
Inhibitors of Angiotensin-Converting Enzyme, Angiotensin II Receptor, Aldosterone, and Renin
Acute nad Chronic Heart Failure: Positive Inotropes, Vasodilators, and Digoxin
Antihypertensive Drugs
Antiarrhythmic Drugs and Strategies
Antithrombotic Agents: Platelet Inhibitors, Anticoagulants, and Fibrinolytics
Lipid-Modifying and Antiatherosclerotic Drugs
Metabolic Syndrome, Hyperglycemia, and Type 2 Diabetes
Which Therapy for Which Condition?
Index
|
|
